共 50 条
- [1] A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study of Brodalumab in Patients With Moderate-to-Severe Crohn's DiseaseAMERICAN JOURNAL OF GASTROENTEROLOGY, 2016, 111 (11): : 1599 - 1607Targan, Stephan R.Feagan, BrianVermeire, SeverinePanaccione, RemoMelmed, Gil Y.Landers, CarolLi, DalinRussell, ChrisNewmark, RichardZhang, NanChon, YunHsu, Yi-HsiangLin, Shao-LeeKlekotka, Paul
- [2] Fontolizumab in Moderate to Severe Crohn's Disease: A Phase 2, Randomized, Double-blind, Placebo-controlled, Multiple-dose StudyINFLAMMATORY BOWEL DISEASES, 2010, 16 (02) : 233 - 242Reinisch, Walterde Villiers, WilliemBene, LaszloSimon, LaszloRacz, IstvanKatz, SeymourAltorjay, IstvanFeagan, BrianRiff, DennisBernstein, Charles N.Hommes, DanielRutgeerts, PaulCortot, AntoineGaspari, MichaelCheng, MayPearce, TillmanSands, Bruce E.
- [3] Onercept for moderate-to-severe Crohn's disease: A randomized, double-blind, placebo-controlled trialCLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2006, 4 (07) : 888 - 893Rutgeerts, PaulSandborn, William J.Fedorak, Richard N.Rachmilewitz, DanielTarabar, DinoGibson, PeterNielsen, Ole HaagenWild, GarySchreiber, StefanRossi, Claudia PenaZignani, Monia
- [4] DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, CROSSOVER TRIAL TO EVALUATE INDUCTION OF CLINICAL RESPONSE IN PATIENTS WITH MODERATE-SEVERE CROHN'S DISEASE TREATED WITH RIFAXIMINGASTROENTEROLOGY, 2018, 154 (01) : S73 - S74Lee, Scott D.Singla, AnandRulyak, Stephen J.Clark-Snustad, Kindra D.
- [5] DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, CROSSOVER TRIAL TO EVALUATE INDUCTION OF CLINICAL RESPONSE IN PATIENTS WITH MODERATE-SEVERE CROHN'S DISEASE TREATED WITH RIFAXIMININFLAMMATORY BOWEL DISEASES, 2018, 24 : S51 - S51Lee, Scott D.Singla, AnandRulyak, Stephen J.Clark-Snustad, Kindra D.
- [6] DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, CROSSOVER TRIAL TO EVALUATE INDUCTION OF CLINICAL RESPONSE IN PATIENTS WITH MODERATE-SEVERE CROHN'S DISEASE TREATED WITH RIFAXIMINGASTROENTEROLOGY, 2018, 154 (06) : S388 - S389Lee, Scott D.Singla, AnandRulyak, Stephen J.Clark-Snustad, Kindra D.
- [7] A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 827 in Subjects With Moderate to Severe Crohn's DiseaseGASTROENTEROLOGY, 2012, 143 (03) : E26 - E26Targan, Stephan R.Feagan, Brian G.Vermeire, SeverinePanaccione, RemoMelmed, Gil Y.Blosch, ConsueloNewmark, RichardZhang, NanChon, YunLin, Shao-LeeKlekotka, Paul
- [8] A randomized, placebo-controlled, double-blind trial of mesalamine in the maintenance of remission of Crohn's diseaseGASTROENTEROLOGY, 1997, 112 (04) : 1069 - 1077Sutherland, LRMartin, FBailey, RJFedorak, RNPoleski, MDallaire, CRossman, RSaibil, FLariviere, LMeyer, DBaker, SJAlvi, AWBass, SBlustein, PKBridges, RJLay, TEvanRosendaal, GMAWatson, MHClermont, RCockeram, AWMabey, MDaCosta, LBeck, ITDepew, WGroll, APaterson, WSimon, JVanner, SDAmore, DSherbaniuk, RCherry, RLalor, EThomson, ABRYacyshyn, BBain, VFisher, DKirdeikis, PHalle, PIrvine, EJCollins, SMCroitoru, KCrowe, SEGoodacre, RLHunt, RHSabena, BJDonnelly, MKhan, MARLangevin, SMenard, DBHaddad, H
- [9] Phase 2/3 randomized, placebo-controlled, double-blind study of SC golimumab induction in moderate to Severe UCJOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2013, 28 : 591 - 591Rutgeerts, P.Feagan, B.Marano, C.Strauss, R.Johanns, J.Zhang, H.Guzzo, C.Colombel, J. F.Reinisch, W.Gibson, P. R.Collins, J.Jarnerot, G.Sandborn, W. J.
- [10] RESTORE: Interim analysis of a Phase 2 study of QBECO SSI for the induction and maintenance of clinical and endoscopic remission in subjects with Moderate to Severe Crohn's DiseaseJOURNAL OF CROHNS & COLITIS, 2021, 15 : S029 - S030Bressler, B.Marshall, J. K.Atkinson, K.Sutcliffe, S.Pankovich, J.Jones, M.Kalyan, S.Gunn, H.